Contravisory Investment Management, Inc. Corcept Therapeutics Inc Transaction History
Contravisory Investment Management, Inc.
- $483 Million
- Q2 2025
A detailed history of Contravisory Investment Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 183 shares of CORT stock, worth $13,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183Holding current value
$13,080% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
471Shares Held
83.8MCall Options Held
1.42MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.18 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$714 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$552 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$439 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$277 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.66B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...